Keep up-to-date with us

Volv Global Insights

All our latest stories, news and insights, including articles and white papers, as well as events, such as webinars and .conferences … and more!

All

Case Studies

Challenges

Clinical Development

Commercial Excellence

Diseases

Earlier Detection

Events

Finding Patients

Insights

Liver Disease

Medical Affairs

News

Oncology

Predicting patient outcomes

Services

Stakeholder

Stratifying patient cohorts

Value & Access HEOR

MASH/NASH: Why Therapeutic Breakthroughs Demand a New Era of Patient Identification

- 05/12/2025

Bridging gaps across the CLL care pathway – Part 2: Knowing When To Treat

- 20/11/2025

Bridging gaps across the CLL care pathway – Part 1: From Signal to Stratification

- 04/11/2025

PCMG AI Symposium 2025: Cutting Through the Hype – Real Value vs. Overpromised Innovation

- 03/11/2025

Beyond the Hype: Volv Global CEO Christopher Rudolf at Frontiers Health 2025

- 02/11/2025

Cracking the Multiple Myeloma Code: Why Systemic Change is Needed to Match Therapeutic Breakthroughs

- 21/10/2025

Where Technology Meets Human: A Call to Unite Clinical Expertise and Real‑World Patient Voices

- 20/10/2025

Unlocking the Future of Type 1 Diabetes Care: Why Earlier Diagnosis Must Match Innovation in Treatment

- 15/10/2025

News Article: AI in healthcare

- 12/09/2025

Case Studies
Challenges
Diseases
Insights
Services
Stakeholder

Back
Clinical Development
Value & Access HEOR
Medical Affairs
Commercial Excellence

Back
Finding Patients
Earlier Detection
Predicting patient outcomes
Stratifying patient cohorts

Back
News
Events

Back
inFlow
inAdvance
inSight

Back
Oncology
Liver Disease

WEBINAR: How AI-driven insights from RWD accelerate the diagnosis and treatment of undiagnosed patients: A case study in alpha-1 antitrypsin deficiency – October 7, 2025

Webinar: How AI-driven insights from RWD accelerate the diagnosis and treatment of undiagnosed patients: a case study

-05/09/2025

Volv Global at the World Orphan Drug Congress Europe 2025

World Orphan Drug Congress Europe 2025 | Volv Global in Amsterdam

-25/08/2025

Volv Global CEO and Founder Christopher Rudolf will speak on optimising rare disease clinical trials with Real World Data at the Rare Trials Summit 2025 in Boston in September.

Optimising Rare Disease Clinical Trials with Real World Data Using NLP & AI: Volv Global at the Rare Trials Summit…

-25/08/2025

Beyond Quick Fixes: How Predictive Modelling Can Redefine Clinical Trial Enrolment

Beyond Quick Fixes: How Predictive Modelling Can Redefine Clinical Trial Enrolment

-21/08/2025

Beyond first diagnosis and first-line curative care: Clinical Management Challenges in Assessing Recurrence Risk and Therapy Decision-Making Post-Curative Cancer Treatment

Beyond Initial Treatment: Navigating Recurrence Risk and Clinical Decisions in Cancer Survivors

-08/07/2025

Unlocking the Full Impact of Breakthrough Therapies in Breast Cancer Through Earlier Detection

Unlocking the Full Impact of Breakthrough Therapies in Breast Cancer Through Earlier Detection

-27/06/2025

Senior woman with oxygen mask at home to illustrate Progressive Pulmonary Fibrosis (PPF)

Progressive Pulmonary Fibrosis: Solving the Puzzle of Poor Disease Control

-23/06/2025

Volv Global posters at American Thoracic Society (ATS) 2025

ATS 2025: 2 posters on the application of an AI model to detect Alpha-1 Antitrypsin Deficiency

-17/04/2025

Swiss Biotech Day 2025

Conference Poster: Swiss Biotech Day 2025, 5th-6th May

-05/04/2025

End of Content.